Advertisement
Advertisement

SLDB

SLDB logo

Solid Biosciences Inc. Common Stock

9.72
USD
Sponsored
-0.17
-1.72%
Aug 26, 15:59 UTC -4
Closed
exchange

After-Market

9.73

+0.01
+0.15%

Solid Biosciences Inc. Common Stock Profile

About

Solid Biosciences LLC is a life science company. It focuses on developing therapies for Duchenne muscular dystrophy. The company is engaged in developing gene therapies, disease modifying therapies and assistive devices, all targeting the various facets of the DMD. Its product candidate includes SGT-001, a gene transfer candidate which is in Phase I/II clinical trial to restore functional dystrophin protein expression in patients' muscles. Solid Biosciences LLC is headquartered in Cambridge, Massachusetts.

Info & Links

CEO

Alexander Cumbo

Headquarters

500 RUTHERFORD AVENUE,THIRD FLOOR
CHARLESTOWN, MA 02129, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.solidbio.com

Auditor

PricewaterhouseCoopers LLP

Share holders

44

Employees

121

Solid Biosciences Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1.04B

Enterprise Value

883.81M

Enterprise Value/EBITDA(ttm)

-4.14

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.57

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-71.35%

Return on Invested Capital(ttm)

-78.48%

Return on Assets(ttm)

-60.58%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-213.58M

Net Income Available to Common(ttm)

-207.10M

Diluted EPS(ttm)

-1.91

Share Statistics

Beta (5Y Monthly)

2.41

52-Week Change

73.57%

S&P 500 52-Week Change

19.02%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

107.23M

Dividend Yield

0.00%

Float4

104.37M

% Held by Insiders

2.66%

% Held by Institutions

81.46%

Balance Sheet

Total Cash(mrq)

378.32M

Total Cash Per Share(mrq)

3.53

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

13.82%

Quick Ratio(mrq)

13.82%

Book Value Per Share(mrq)

3.56

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.69

Free Cash Flow(ytd)

-100.13M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement